Generated by GPT-5-mini| Ethicon | |
|---|---|
| Name | Ethicon |
| Type | Subsidiary |
| Industry | Medical devices |
| Founded | 1915 |
| Founder | Paul Winchell; Others |
| Headquarters | Cincinnati, Ohio, United States |
| Key people | Joseph Jimenez; Alex Gorsky; Hakan Mogren |
| Products | Surgical sutures; staplers; energy devices; wound closure systems; hernia mesh |
| Parent | Johnson & Johnson |
Ethicon Ethicon is a medical device manufacturer specializing in surgical technologies, best known for sutures, staplers, mesh, and energy-based instruments. Founded in the early 20th century, the company became a major subsidiary of Johnson & Johnson and has played roles in developments alongside institutions like Mayo Clinic, Cleveland Clinic, and regulatory bodies such as the U.S. Food and Drug Administration and European Medicines Agency. Ethicon products are widely used in hospitals affiliated with Johns Hopkins Hospital, Massachusetts General Hospital, and multinational health systems including National Health Service (England) facilities.
Ethicon traces origins to early commercial suture manufacturing that paralleled advances at institutions such as Harvard Medical School, Stanford University, and innovations by inventors connected to Bell Labs. The firm expanded during the 20th century amid consolidation in the medical device sector involving conglomerates like Becton Dickinson and mergers similar to those of Medtronic and Abbott Laboratories. Acquisition by Johnson & Johnson integrated Ethicon into a corporate portfolio that includes DePuy Synthes and Janssen Pharmaceuticals. Throughout its history Ethicon engaged with regulatory milestones such as compliance with the Medical Device Amendments of 1976 and litigation trends exemplified by large-scale product liability cases like those faced by Purdue Pharma and class actions concerning implantable devices.
Ethicon's product range spans traditional materials and modern platforms used in facilities like Hospital of the University of Pennsylvania and Mount Sinai Health System. Core offerings include sutures and wound closure systems comparable to innovations from Covidien and 3M; mechanical staplers and disposable curved instruments used in minimally invasive surgery at centers such as Memorial Sloan Kettering Cancer Center; surgical mesh for hernia repair in procedures performed at Cleveland Clinic Abu Dhabi; and energy devices competing with products from Intuitive Surgical and Olympus Corporation. The company invests in research efforts with universities including University of California, San Francisco and Johns Hopkins University School of Medicine to develop hemostatic agents, absorbable polymers, and barbed suture technology analogous to advances reported by ETH Zurich and Imperial College London. Ethicon's portfolio features resorbable polymers related to work from DuPont materials science and collaborations reminiscent of partnerships between GE Healthcare and academic engineering departments.
Ethicon devices are applied across surgical specialties practiced at institutions like Stanford Health Care and UCLA Health. In general surgery, sutures and mesh are used in hernia repair protocols taught in programs at Royal College of Surgeons and American College of Surgeons. In gynecology and urogynecology, mesh and fixation systems are involved in pelvic organ prolapse and stress urinary incontinence procedures performed in centers such as Cleveland Clinic and Guy's and St Thomas' NHS Foundation Trust. Cardiothoracic teams at Mayo Clinic employ stapling systems in lobectomy and esophagectomy, while bariatric surgeons at Brigham and Women's Hospital use staplers and energy devices for gastric bypass. Minimally invasive and robotic-assisted operations using Ethicon products intersect with technologies from Intuitive Surgical and training programs at Oxford University Hospitals.
Ethicon devices have been subject to regulatory review by agencies including the U.S. Food and Drug Administration and European Medicines Agency, and to litigation patterns similar to those involving Johnson & Johnson's other surgical products. Mesh products and certain hernia devices prompted postmarket surveillance, safety communications, and recall actions comparable to issues seen with devices from Boston Scientific and Coloplast. Regulatory oversight referenced standards from International Organization for Standardization directives and reporting under systems used by MedWatch and national competent authorities. Safety concerns have led to studies published in journals associated with The Lancet and New England Journal of Medicine and to involvement by advisory panels such as those convened by the U.S. Department of Health and Human Services.
Ethicon operates as a business unit within Johnson & Johnson, alongside other subsidiaries such as DePuy Synthes and Janssen Pharmaceuticals. Executive leadership has included figures who have held roles across multinational firms like Pfizer and GlaxoSmithKline, and board oversight reflects governance norms seen at corporations like Procter & Gamble and General Electric. Ethicon's commercial activities engage global supply chains that intersect with manufacturers in China, Germany, and Ireland, and it participates in procurement with hospital systems such as Kaiser Permanente and purchasing consortia like Vizient. Strategic research collaborations mirror alliances between industry and academia exemplified by partnerships of Siemens Healthineers with universities.
Category:Johnson & Johnson subsidiaries